nodes	percent_of_prediction	percent_of_DWPC	metapath
Lenalidomide—PTGS2—obesity	0.324	1	CbGaD
Lenalidomide—TNFSF11—jaw skeleton—obesity	0.0518	0.355	CbGeAlD
Lenalidomide—TNFSF11—respiratory system—obesity	0.00775	0.0531	CbGeAlD
Lenalidomide—PTGS2—ovarian follicle—obesity	0.00764	0.0523	CbGeAlD
Lenalidomide—CDH5—respiratory system—obesity	0.00583	0.0399	CbGeAlD
Lenalidomide—CDH5—adrenal cortex—obesity	0.00489	0.0335	CbGeAlD
Lenalidomide—TNFSF11—adrenal gland—obesity	0.0047	0.0322	CbGeAlD
Lenalidomide—CDH5—cardiovascular system—obesity	0.00447	0.0306	CbGeAlD
Lenalidomide—TNFSF11—endocrine gland—obesity	0.00407	0.0279	CbGeAlD
Lenalidomide—CDH5—pituitary gland—obesity	0.00395	0.0271	CbGeAlD
Lenalidomide—CDH5—adipose tissue—obesity	0.00394	0.027	CbGeAlD
Lenalidomide—CRBN—islet of Langerhans—obesity	0.00392	0.0269	CbGeAlD
Lenalidomide—CRBN—respiratory system—obesity	0.0037	0.0254	CbGeAlD
Lenalidomide—CDH5—adrenal gland—obesity	0.00353	0.0242	CbGeAlD
Lenalidomide—CRBN—adrenal cortex—obesity	0.00311	0.0213	CbGeAlD
Lenalidomide—CDH5—endocrine gland—obesity	0.00306	0.021	CbGeAlD
Lenalidomide—CDH5—liver—obesity	0.00276	0.0189	CbGeAlD
Lenalidomide—CRBN—pituitary gland—obesity	0.00251	0.0172	CbGeAlD
Lenalidomide—CRBN—adipose tissue—obesity	0.0025	0.0171	CbGeAlD
Lenalidomide—CRBN—digestive system—obesity	0.00235	0.0161	CbGeAlD
Lenalidomide—CRBN—adrenal gland—obesity	0.00224	0.0154	CbGeAlD
Lenalidomide—Pomalidomide—TNF—obesity	0.00224	0.342	CrCbGaD
Lenalidomide—CRBN—endocrine gland—obesity	0.00195	0.0133	CbGeAlD
Lenalidomide—CRBN—liver—obesity	0.00175	0.012	CbGeAlD
Lenalidomide—PTGS2—gall bladder—obesity	0.00163	0.0112	CbGeAlD
Lenalidomide—Thalidomide—TNF—obesity	0.00144	0.221	CrCbGaD
Lenalidomide—Thalidomide—CYP2E1—obesity	0.00111	0.17	CrCbGaD
Lenalidomide—PTGS2—islet of Langerhans—obesity	0.00107	0.00732	CbGeAlD
Lenalidomide—Pomalidomide—PTGS2—obesity	0.00106	0.163	CrCbGaD
Lenalidomide—PTGS2—respiratory system—obesity	0.00101	0.00691	CbGeAlD
Lenalidomide—PTGS2—adrenal cortex—obesity	0.000846	0.0058	CbGeAlD
Lenalidomide—PTGS2—cardiovascular system—obesity	0.000772	0.00529	CbGeAlD
Lenalidomide—Thalidomide—PTGS2—obesity	0.000684	0.105	CrCbGaD
Lenalidomide—PTGS2—pituitary gland—obesity	0.000684	0.00469	CbGeAlD
Lenalidomide—PTGS2—adipose tissue—obesity	0.000681	0.00467	CbGeAlD
Lenalidomide—ABCB1—islet of Langerhans—obesity	0.000661	0.00453	CbGeAlD
Lenalidomide—PTGS2—digestive system—obesity	0.000641	0.00439	CbGeAlD
Lenalidomide—ABCB1—respiratory system—obesity	0.000624	0.00427	CbGeAlD
Lenalidomide—PTGS2—adrenal gland—obesity	0.000611	0.00419	CbGeAlD
Lenalidomide—PTGS2—endocrine gland—obesity	0.00053	0.00363	CbGeAlD
Lenalidomide—ABCB1—adrenal cortex—obesity	0.000524	0.00359	CbGeAlD
Lenalidomide—ABCB1—cardiovascular system—obesity	0.000478	0.00327	CbGeAlD
Lenalidomide—PTGS2—liver—obesity	0.000478	0.00327	CbGeAlD
Lenalidomide—ABCB1—pituitary gland—obesity	0.000423	0.0029	CbGeAlD
Lenalidomide—ABCB1—adipose tissue—obesity	0.000421	0.00289	CbGeAlD
Lenalidomide—ABCB1—digestive system—obesity	0.000397	0.00272	CbGeAlD
Lenalidomide—ABCB1—adrenal gland—obesity	0.000378	0.00259	CbGeAlD
Lenalidomide—ABCB1—endocrine gland—obesity	0.000328	0.00225	CbGeAlD
Lenalidomide—ABCB1—liver—obesity	0.000295	0.00202	CbGeAlD
Lenalidomide—Muscle spasms—Bupropion—obesity	0.000169	0.000478	CcSEcCtD
Lenalidomide—Infection—Orlistat—obesity	0.000169	0.000478	CcSEcCtD
Lenalidomide—Breast disorder—Topiramate—obesity	0.000168	0.000475	CcSEcCtD
Lenalidomide—Dry mouth—Sibutramine—obesity	0.000168	0.000475	CcSEcCtD
Lenalidomide—Aspartate aminotransferase increased—Topiramate—obesity	0.000168	0.000474	CcSEcCtD
Lenalidomide—Toxic epidermal necrolysis—Topiramate—obesity	0.000168	0.000474	CcSEcCtD
Lenalidomide—Nervous system disorder—Orlistat—obesity	0.000167	0.000472	CcSEcCtD
Lenalidomide—Nasopharyngitis—Topiramate—obesity	0.000166	0.00047	CcSEcCtD
Lenalidomide—Confusional state—Sibutramine—obesity	0.000166	0.000469	CcSEcCtD
Lenalidomide—Vision blurred—Bupropion—obesity	0.000166	0.000469	CcSEcCtD
Lenalidomide—Skin disorder—Orlistat—obesity	0.000165	0.000467	CcSEcCtD
Lenalidomide—Tremor—Bupropion—obesity	0.000165	0.000466	CcSEcCtD
Lenalidomide—Gastritis—Topiramate—obesity	0.000165	0.000466	CcSEcCtD
Lenalidomide—Oedema—Sibutramine—obesity	0.000165	0.000466	CcSEcCtD
Lenalidomide—Hyperhidrosis—Orlistat—obesity	0.000164	0.000465	CcSEcCtD
Lenalidomide—Alanine aminotransferase increased—Topiramate—obesity	0.000164	0.000464	CcSEcCtD
Lenalidomide—Muscular weakness—Topiramate—obesity	0.000164	0.000464	CcSEcCtD
Lenalidomide—Infection—Sibutramine—obesity	0.000164	0.000463	CcSEcCtD
Lenalidomide—Ill-defined disorder—Bupropion—obesity	0.000163	0.000461	CcSEcCtD
Lenalidomide—Anaemia—Bupropion—obesity	0.000163	0.00046	CcSEcCtD
Lenalidomide—Shock—Sibutramine—obesity	0.000162	0.000458	CcSEcCtD
Lenalidomide—Abdominal distension—Topiramate—obesity	0.000162	0.000458	CcSEcCtD
Lenalidomide—Agitation—Bupropion—obesity	0.000162	0.000457	CcSEcCtD
Lenalidomide—Thrombocytopenia—Sibutramine—obesity	0.000161	0.000456	CcSEcCtD
Lenalidomide—Dysphagia—Topiramate—obesity	0.000161	0.000455	CcSEcCtD
Lenalidomide—Asthma—Topiramate—obesity	0.000161	0.000455	CcSEcCtD
Lenalidomide—Angioedema—Bupropion—obesity	0.000161	0.000454	CcSEcCtD
Lenalidomide—Tachycardia—Sibutramine—obesity	0.000161	0.000454	CcSEcCtD
Lenalidomide—Skin disorder—Sibutramine—obesity	0.00016	0.000452	CcSEcCtD
Lenalidomide—Hyperhidrosis—Sibutramine—obesity	0.000159	0.00045	CcSEcCtD
Lenalidomide—Malaise—Bupropion—obesity	0.000159	0.000448	CcSEcCtD
Lenalidomide—Vertigo—Bupropion—obesity	0.000158	0.000447	CcSEcCtD
Lenalidomide—Syncope—Bupropion—obesity	0.000158	0.000446	CcSEcCtD
Lenalidomide—Pancreatitis—Topiramate—obesity	0.000158	0.000446	CcSEcCtD
Lenalidomide—Leukopenia—Bupropion—obesity	0.000157	0.000445	CcSEcCtD
Lenalidomide—Anorexia—Sibutramine—obesity	0.000157	0.000444	CcSEcCtD
Lenalidomide—Sweating increased—Topiramate—obesity	0.000157	0.000443	CcSEcCtD
Lenalidomide—Angina pectoris—Topiramate—obesity	0.000157	0.000443	CcSEcCtD
Lenalidomide—Palpitations—Bupropion—obesity	0.000155	0.000439	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Orlistat—obesity	0.000155	0.000438	CcSEcCtD
Lenalidomide—Bronchitis—Topiramate—obesity	0.000155	0.000437	CcSEcCtD
Lenalidomide—Loss of consciousness—Bupropion—obesity	0.000155	0.000437	CcSEcCtD
Lenalidomide—Abdominal discomfort—Topiramate—obesity	0.000154	0.000436	CcSEcCtD
Lenalidomide—Insomnia—Orlistat—obesity	0.000154	0.000435	CcSEcCtD
Lenalidomide—Hypotension—Sibutramine—obesity	0.000154	0.000435	CcSEcCtD
Lenalidomide—Cough—Bupropion—obesity	0.000153	0.000434	CcSEcCtD
Lenalidomide—Paraesthesia—Orlistat—obesity	0.000153	0.000432	CcSEcCtD
Lenalidomide—Pancytopenia—Topiramate—obesity	0.000153	0.000432	CcSEcCtD
Lenalidomide—Hypertension—Bupropion—obesity	0.000152	0.000429	CcSEcCtD
Lenalidomide—Dysuria—Topiramate—obesity	0.00015	0.000425	CcSEcCtD
Lenalidomide—Neutropenia—Topiramate—obesity	0.00015	0.000425	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Sibutramine—obesity	0.00015	0.000424	CcSEcCtD
Lenalidomide—Dyspepsia—Orlistat—obesity	0.00015	0.000423	CcSEcCtD
Lenalidomide—Chest pain—Bupropion—obesity	0.00015	0.000423	CcSEcCtD
Lenalidomide—Myalgia—Bupropion—obesity	0.00015	0.000423	CcSEcCtD
Lenalidomide—Arthralgia—Bupropion—obesity	0.00015	0.000423	CcSEcCtD
Lenalidomide—Upper respiratory tract infection—Topiramate—obesity	0.000149	0.000423	CcSEcCtD
Lenalidomide—Anxiety—Bupropion—obesity	0.000149	0.000422	CcSEcCtD
Lenalidomide—Insomnia—Sibutramine—obesity	0.000149	0.000421	CcSEcCtD
Lenalidomide—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000149	0.00042	CcSEcCtD
Lenalidomide—Pollakiuria—Topiramate—obesity	0.000149	0.00042	CcSEcCtD
Lenalidomide—Erectile dysfunction—Topiramate—obesity	0.000148	0.000419	CcSEcCtD
Lenalidomide—Discomfort—Bupropion—obesity	0.000148	0.000418	CcSEcCtD
Lenalidomide—Decreased appetite—Orlistat—obesity	0.000148	0.000418	CcSEcCtD
Lenalidomide—Paraesthesia—Sibutramine—obesity	0.000148	0.000418	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Orlistat—obesity	0.000147	0.000415	CcSEcCtD
Lenalidomide—Dyspnoea—Sibutramine—obesity	0.000147	0.000415	CcSEcCtD
Lenalidomide—Photosensitivity reaction—Topiramate—obesity	0.000147	0.000415	CcSEcCtD
Lenalidomide—Fatigue—Orlistat—obesity	0.000147	0.000415	CcSEcCtD
Lenalidomide—Dry mouth—Bupropion—obesity	0.000146	0.000414	CcSEcCtD
Lenalidomide—Somnolence—Sibutramine—obesity	0.000146	0.000414	CcSEcCtD
Lenalidomide—Weight increased—Topiramate—obesity	0.000146	0.000414	CcSEcCtD
Lenalidomide—Weight decreased—Topiramate—obesity	0.000146	0.000411	CcSEcCtD
Lenalidomide—Pain—Orlistat—obesity	0.000146	0.000411	CcSEcCtD
Lenalidomide—Hyperglycaemia—Topiramate—obesity	0.000145	0.00041	CcSEcCtD
Lenalidomide—Dyspepsia—Sibutramine—obesity	0.000145	0.00041	CcSEcCtD
Lenalidomide—Confusional state—Bupropion—obesity	0.000145	0.000409	CcSEcCtD
Lenalidomide—Pneumonia—Topiramate—obesity	0.000144	0.000408	CcSEcCtD
Lenalidomide—Oedema—Bupropion—obesity	0.000144	0.000406	CcSEcCtD
Lenalidomide—Infestation NOS—Topiramate—obesity	0.000143	0.000405	CcSEcCtD
Lenalidomide—Infestation—Topiramate—obesity	0.000143	0.000405	CcSEcCtD
Lenalidomide—Decreased appetite—Sibutramine—obesity	0.000143	0.000405	CcSEcCtD
Lenalidomide—Depression—Topiramate—obesity	0.000143	0.000404	CcSEcCtD
Lenalidomide—Infection—Bupropion—obesity	0.000143	0.000403	CcSEcCtD
Lenalidomide—Stevens-Johnson syndrome—Topiramate—obesity	0.000142	0.000402	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Sibutramine—obesity	0.000142	0.000402	CcSEcCtD
Lenalidomide—Shock—Bupropion—obesity	0.000141	0.000399	CcSEcCtD
Lenalidomide—Renal failure—Topiramate—obesity	0.000141	0.000399	CcSEcCtD
Lenalidomide—Constipation—Sibutramine—obesity	0.000141	0.000398	CcSEcCtD
Lenalidomide—Pain—Sibutramine—obesity	0.000141	0.000398	CcSEcCtD
Lenalidomide—Nervous system disorder—Bupropion—obesity	0.000141	0.000398	CcSEcCtD
Lenalidomide—Neuropathy peripheral—Topiramate—obesity	0.000141	0.000397	CcSEcCtD
Lenalidomide—Thrombocytopenia—Bupropion—obesity	0.000141	0.000397	CcSEcCtD
Lenalidomide—Feeling abnormal—Orlistat—obesity	0.00014	0.000396	CcSEcCtD
Lenalidomide—Tachycardia—Bupropion—obesity	0.00014	0.000396	CcSEcCtD
Lenalidomide—Stomatitis—Topiramate—obesity	0.00014	0.000395	CcSEcCtD
Lenalidomide—Skin disorder—Bupropion—obesity	0.000139	0.000394	CcSEcCtD
Lenalidomide—Conjunctivitis—Topiramate—obesity	0.000139	0.000394	CcSEcCtD
Lenalidomide—Urinary tract infection—Topiramate—obesity	0.000139	0.000394	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Orlistat—obesity	0.000139	0.000393	CcSEcCtD
Lenalidomide—Hyperhidrosis—Bupropion—obesity	0.000139	0.000392	CcSEcCtD
Lenalidomide—Anorexia—Bupropion—obesity	0.000137	0.000387	CcSEcCtD
Lenalidomide—Haematuria—Topiramate—obesity	0.000137	0.000387	CcSEcCtD
Lenalidomide—Feeling abnormal—Sibutramine—obesity	0.000136	0.000384	CcSEcCtD
Lenalidomide—Epistaxis—Topiramate—obesity	0.000135	0.000382	CcSEcCtD
Lenalidomide—Urticaria—Orlistat—obesity	0.000135	0.000382	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Sibutramine—obesity	0.000135	0.000381	CcSEcCtD
Lenalidomide—Sinusitis—Topiramate—obesity	0.000135	0.00038	CcSEcCtD
Lenalidomide—Body temperature increased—Orlistat—obesity	0.000135	0.00038	CcSEcCtD
Lenalidomide—Abdominal pain—Orlistat—obesity	0.000135	0.00038	CcSEcCtD
Lenalidomide—Hypotension—Bupropion—obesity	0.000134	0.000379	CcSEcCtD
Lenalidomide—Agranulocytosis—Topiramate—obesity	0.000134	0.000378	CcSEcCtD
Lenalidomide—Bradycardia—Topiramate—obesity	0.000131	0.000371	CcSEcCtD
Lenalidomide—Urticaria—Sibutramine—obesity	0.000131	0.00037	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Bupropion—obesity	0.000131	0.00037	CcSEcCtD
Lenalidomide—Abdominal pain—Sibutramine—obesity	0.00013	0.000368	CcSEcCtD
Lenalidomide—Body temperature increased—Sibutramine—obesity	0.00013	0.000368	CcSEcCtD
Lenalidomide—Insomnia—Bupropion—obesity	0.00013	0.000367	CcSEcCtD
Lenalidomide—Haemoglobin—Topiramate—obesity	0.000129	0.000366	CcSEcCtD
Lenalidomide—Rhinitis—Topiramate—obesity	0.000129	0.000365	CcSEcCtD
Lenalidomide—Paraesthesia—Bupropion—obesity	0.000129	0.000364	CcSEcCtD
Lenalidomide—Haemorrhage—Topiramate—obesity	0.000129	0.000364	CcSEcCtD
Lenalidomide—Hepatitis—Topiramate—obesity	0.000129	0.000364	CcSEcCtD
Lenalidomide—Hallucination—Topiramate—obesity	0.000128	0.000362	CcSEcCtD
Lenalidomide—Hypoaesthesia—Topiramate—obesity	0.000128	0.000362	CcSEcCtD
Lenalidomide—Dyspnoea—Bupropion—obesity	0.000128	0.000362	CcSEcCtD
Lenalidomide—Pharyngitis—Topiramate—obesity	0.000128	0.000361	CcSEcCtD
Lenalidomide—Somnolence—Bupropion—obesity	0.000128	0.000361	CcSEcCtD
Lenalidomide—Urinary tract disorder—Topiramate—obesity	0.000127	0.000359	CcSEcCtD
Lenalidomide—Oedema peripheral—Topiramate—obesity	0.000127	0.000359	CcSEcCtD
Lenalidomide—Connective tissue disorder—Topiramate—obesity	0.000127	0.000358	CcSEcCtD
Lenalidomide—Dyspepsia—Bupropion—obesity	0.000126	0.000357	CcSEcCtD
Lenalidomide—Urethral disorder—Topiramate—obesity	0.000126	0.000357	CcSEcCtD
Lenalidomide—Hypersensitivity—Orlistat—obesity	0.000125	0.000354	CcSEcCtD
Lenalidomide—Decreased appetite—Bupropion—obesity	0.000125	0.000353	CcSEcCtD
Lenalidomide—Visual impairment—Topiramate—obesity	0.000124	0.000351	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Bupropion—obesity	0.000124	0.00035	CcSEcCtD
Lenalidomide—Fatigue—Bupropion—obesity	0.000124	0.00035	CcSEcCtD
Lenalidomide—Constipation—Bupropion—obesity	0.000123	0.000347	CcSEcCtD
Lenalidomide—Pain—Bupropion—obesity	0.000123	0.000347	CcSEcCtD
Lenalidomide—Asthenia—Orlistat—obesity	0.000122	0.000345	CcSEcCtD
Lenalidomide—Erythema multiforme—Topiramate—obesity	0.000122	0.000344	CcSEcCtD
Lenalidomide—Hypersensitivity—Sibutramine—obesity	0.000121	0.000343	CcSEcCtD
Lenalidomide—Pruritus—Orlistat—obesity	0.00012	0.00034	CcSEcCtD
Lenalidomide—Eye disorder—Topiramate—obesity	0.00012	0.00034	CcSEcCtD
Lenalidomide—Tinnitus—Topiramate—obesity	0.00012	0.000339	CcSEcCtD
Lenalidomide—Cardiac disorder—Topiramate—obesity	0.000119	0.000338	CcSEcCtD
Lenalidomide—Flushing—Topiramate—obesity	0.000119	0.000338	CcSEcCtD
Lenalidomide—Feeling abnormal—Bupropion—obesity	0.000118	0.000334	CcSEcCtD
Lenalidomide—Asthenia—Sibutramine—obesity	0.000118	0.000334	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Bupropion—obesity	0.000117	0.000332	CcSEcCtD
Lenalidomide—Angiopathy—Topiramate—obesity	0.000117	0.00033	CcSEcCtD
Lenalidomide—Pruritus—Sibutramine—obesity	0.000117	0.000329	CcSEcCtD
Lenalidomide—Diarrhoea—Orlistat—obesity	0.000116	0.000329	CcSEcCtD
Lenalidomide—Immune system disorder—Topiramate—obesity	0.000116	0.000329	CcSEcCtD
Lenalidomide—Mediastinal disorder—Topiramate—obesity	0.000116	0.000328	CcSEcCtD
Lenalidomide—Chills—Topiramate—obesity	0.000116	0.000327	CcSEcCtD
Lenalidomide—Urticaria—Bupropion—obesity	0.000114	0.000322	CcSEcCtD
Lenalidomide—Alopecia—Topiramate—obesity	0.000114	0.000322	CcSEcCtD
Lenalidomide—Body temperature increased—Bupropion—obesity	0.000113	0.000321	CcSEcCtD
Lenalidomide—Abdominal pain—Bupropion—obesity	0.000113	0.000321	CcSEcCtD
Lenalidomide—Mental disorder—Topiramate—obesity	0.000113	0.000319	CcSEcCtD
Lenalidomide—Diarrhoea—Sibutramine—obesity	0.000113	0.000319	CcSEcCtD
Lenalidomide—Dizziness—Orlistat—obesity	0.000113	0.000318	CcSEcCtD
Lenalidomide—Erythema—Topiramate—obesity	0.000112	0.000317	CcSEcCtD
Lenalidomide—Malnutrition—Topiramate—obesity	0.000112	0.000317	CcSEcCtD
Lenalidomide—Flatulence—Topiramate—obesity	0.00011	0.000312	CcSEcCtD
Lenalidomide—Tension—Topiramate—obesity	0.00011	0.000311	CcSEcCtD
Lenalidomide—Dysgeusia—Topiramate—obesity	0.00011	0.00031	CcSEcCtD
Lenalidomide—Dizziness—Sibutramine—obesity	0.000109	0.000308	CcSEcCtD
Lenalidomide—Nervousness—Topiramate—obesity	0.000109	0.000308	CcSEcCtD
Lenalidomide—Back pain—Topiramate—obesity	0.000108	0.000306	CcSEcCtD
Lenalidomide—Vomiting—Orlistat—obesity	0.000108	0.000306	CcSEcCtD
Lenalidomide—Muscle spasms—Topiramate—obesity	0.000108	0.000305	CcSEcCtD
Lenalidomide—Rash—Orlistat—obesity	0.000107	0.000303	CcSEcCtD
Lenalidomide—Dermatitis—Orlistat—obesity	0.000107	0.000303	CcSEcCtD
Lenalidomide—Headache—Orlistat—obesity	0.000107	0.000301	CcSEcCtD
Lenalidomide—Hypersensitivity—Bupropion—obesity	0.000106	0.000299	CcSEcCtD
Lenalidomide—Vision blurred—Topiramate—obesity	0.000106	0.000299	CcSEcCtD
Lenalidomide—Tremor—Topiramate—obesity	0.000105	0.000297	CcSEcCtD
Lenalidomide—Vomiting—Sibutramine—obesity	0.000105	0.000296	CcSEcCtD
Lenalidomide—Ill-defined disorder—Topiramate—obesity	0.000104	0.000294	CcSEcCtD
Lenalidomide—Rash—Sibutramine—obesity	0.000104	0.000294	CcSEcCtD
Lenalidomide—Dermatitis—Sibutramine—obesity	0.000104	0.000293	CcSEcCtD
Lenalidomide—Anaemia—Topiramate—obesity	0.000104	0.000293	CcSEcCtD
Lenalidomide—Headache—Sibutramine—obesity	0.000103	0.000292	CcSEcCtD
Lenalidomide—Asthenia—Bupropion—obesity	0.000103	0.000291	CcSEcCtD
Lenalidomide—Agitation—Topiramate—obesity	0.000103	0.000291	CcSEcCtD
Lenalidomide—Pruritus—Bupropion—obesity	0.000102	0.000287	CcSEcCtD
Lenalidomide—Nausea—Orlistat—obesity	0.000101	0.000286	CcSEcCtD
Lenalidomide—Malaise—Topiramate—obesity	0.000101	0.000286	CcSEcCtD
Lenalidomide—Vertigo—Topiramate—obesity	0.000101	0.000285	CcSEcCtD
Lenalidomide—Syncope—Topiramate—obesity	0.0001	0.000284	CcSEcCtD
Lenalidomide—Leukopenia—Topiramate—obesity	0.0001	0.000284	CcSEcCtD
Lenalidomide—Palpitations—Topiramate—obesity	9.9e-05	0.00028	CcSEcCtD
Lenalidomide—Loss of consciousness—Topiramate—obesity	9.85e-05	0.000278	CcSEcCtD
Lenalidomide—Diarrhoea—Bupropion—obesity	9.82e-05	0.000278	CcSEcCtD
Lenalidomide—Nausea—Sibutramine—obesity	9.78e-05	0.000277	CcSEcCtD
Lenalidomide—Cough—Topiramate—obesity	9.78e-05	0.000276	CcSEcCtD
Lenalidomide—Hypertension—Topiramate—obesity	9.68e-05	0.000274	CcSEcCtD
Lenalidomide—Myalgia—Topiramate—obesity	9.54e-05	0.00027	CcSEcCtD
Lenalidomide—Chest pain—Topiramate—obesity	9.54e-05	0.00027	CcSEcCtD
Lenalidomide—Arthralgia—Topiramate—obesity	9.54e-05	0.00027	CcSEcCtD
Lenalidomide—Anxiety—Topiramate—obesity	9.51e-05	0.000269	CcSEcCtD
Lenalidomide—Dizziness—Bupropion—obesity	9.49e-05	0.000268	CcSEcCtD
Lenalidomide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	9.47e-05	0.000268	CcSEcCtD
Lenalidomide—Discomfort—Topiramate—obesity	9.43e-05	0.000267	CcSEcCtD
Lenalidomide—Dry mouth—Topiramate—obesity	9.33e-05	0.000264	CcSEcCtD
Lenalidomide—Confusional state—Topiramate—obesity	9.22e-05	0.000261	CcSEcCtD
Lenalidomide—Oedema—Topiramate—obesity	9.15e-05	0.000259	CcSEcCtD
Lenalidomide—Vomiting—Bupropion—obesity	9.13e-05	0.000258	CcSEcCtD
Lenalidomide—Infection—Topiramate—obesity	9.09e-05	0.000257	CcSEcCtD
Lenalidomide—Rash—Bupropion—obesity	9.05e-05	0.000256	CcSEcCtD
Lenalidomide—Dermatitis—Bupropion—obesity	9.04e-05	0.000256	CcSEcCtD
Lenalidomide—Shock—Topiramate—obesity	9e-05	0.000254	CcSEcCtD
Lenalidomide—Headache—Bupropion—obesity	8.99e-05	0.000254	CcSEcCtD
Lenalidomide—Nervous system disorder—Topiramate—obesity	8.97e-05	0.000254	CcSEcCtD
Lenalidomide—Thrombocytopenia—Topiramate—obesity	8.95e-05	0.000253	CcSEcCtD
Lenalidomide—Tachycardia—Topiramate—obesity	8.93e-05	0.000252	CcSEcCtD
Lenalidomide—Skin disorder—Topiramate—obesity	8.88e-05	0.000251	CcSEcCtD
Lenalidomide—Hyperhidrosis—Topiramate—obesity	8.84e-05	0.00025	CcSEcCtD
Lenalidomide—Anorexia—Topiramate—obesity	8.72e-05	0.000246	CcSEcCtD
Lenalidomide—Hypotension—Topiramate—obesity	8.55e-05	0.000242	CcSEcCtD
Lenalidomide—Nausea—Bupropion—obesity	8.53e-05	0.000241	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Topiramate—obesity	8.33e-05	0.000236	CcSEcCtD
Lenalidomide—Insomnia—Topiramate—obesity	8.27e-05	0.000234	CcSEcCtD
Lenalidomide—Paraesthesia—Topiramate—obesity	8.21e-05	0.000232	CcSEcCtD
Lenalidomide—Dyspnoea—Topiramate—obesity	8.15e-05	0.000231	CcSEcCtD
Lenalidomide—Somnolence—Topiramate—obesity	8.13e-05	0.00023	CcSEcCtD
Lenalidomide—Dyspepsia—Topiramate—obesity	8.05e-05	0.000228	CcSEcCtD
Lenalidomide—Decreased appetite—Topiramate—obesity	7.95e-05	0.000225	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Topiramate—obesity	7.9e-05	0.000223	CcSEcCtD
Lenalidomide—Fatigue—Topiramate—obesity	7.89e-05	0.000223	CcSEcCtD
Lenalidomide—Pain—Topiramate—obesity	7.82e-05	0.000221	CcSEcCtD
Lenalidomide—Constipation—Topiramate—obesity	7.82e-05	0.000221	CcSEcCtD
Lenalidomide—Feeling abnormal—Topiramate—obesity	7.54e-05	0.000213	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Topiramate—obesity	7.48e-05	0.000211	CcSEcCtD
Lenalidomide—Urticaria—Topiramate—obesity	7.27e-05	0.000205	CcSEcCtD
Lenalidomide—Abdominal pain—Topiramate—obesity	7.23e-05	0.000204	CcSEcCtD
Lenalidomide—Body temperature increased—Topiramate—obesity	7.23e-05	0.000204	CcSEcCtD
Lenalidomide—Hypersensitivity—Topiramate—obesity	6.74e-05	0.000191	CcSEcCtD
Lenalidomide—Asthenia—Topiramate—obesity	6.56e-05	0.000186	CcSEcCtD
Lenalidomide—Pruritus—Topiramate—obesity	6.47e-05	0.000183	CcSEcCtD
Lenalidomide—Diarrhoea—Topiramate—obesity	6.26e-05	0.000177	CcSEcCtD
Lenalidomide—Dizziness—Topiramate—obesity	6.05e-05	0.000171	CcSEcCtD
Lenalidomide—Vomiting—Topiramate—obesity	5.82e-05	0.000164	CcSEcCtD
Lenalidomide—Rash—Topiramate—obesity	5.77e-05	0.000163	CcSEcCtD
Lenalidomide—Dermatitis—Topiramate—obesity	5.76e-05	0.000163	CcSEcCtD
Lenalidomide—Headache—Topiramate—obesity	5.73e-05	0.000162	CcSEcCtD
Lenalidomide—Nausea—Topiramate—obesity	5.43e-05	0.000154	CcSEcCtD
Lenalidomide—ABCB1—Metabolism—ENPP1—obesity	2.67e-05	0.000158	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ALOX12—obesity	2.67e-05	0.000158	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—TFRC—obesity	2.67e-05	0.000158	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—LPL—obesity	2.64e-05	0.000156	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—obesity	2.64e-05	0.000156	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—obesity	2.63e-05	0.000155	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ACP5—obesity	2.61e-05	0.000154	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—HMGCS1—obesity	2.59e-05	0.000153	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—RBP4—obesity	2.59e-05	0.000153	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—GPX1—obesity	2.58e-05	0.000152	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—PIK3CA—obesity	2.58e-05	0.000152	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—obesity	2.58e-05	0.000152	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—G6PD—obesity	2.55e-05	0.00015	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—HK1—obesity	2.52e-05	0.000148	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—SREBF2—obesity	2.52e-05	0.000148	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—CD36—obesity	2.51e-05	0.000148	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PLIN1—obesity	2.51e-05	0.000148	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ACADM—obesity	2.51e-05	0.000148	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PNPLA2—obesity	2.51e-05	0.000148	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ANGPTL4—obesity	2.51e-05	0.000148	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PFKFB3—obesity	2.51e-05	0.000148	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SAT1—obesity	2.51e-05	0.000148	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—obesity	2.46e-05	0.000145	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CST3—obesity	2.45e-05	0.000144	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PRKAR2B—obesity	2.45e-05	0.000144	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—OXCT1—obesity	2.44e-05	0.000144	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ACACB—obesity	2.44e-05	0.000144	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CYTB—obesity	2.44e-05	0.000144	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—DCN—obesity	2.43e-05	0.000143	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—LPA—obesity	2.43e-05	0.000143	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PNLIP—obesity	2.38e-05	0.000141	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SRD5A1—obesity	2.38e-05	0.000141	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—LPIN1—obesity	2.38e-05	0.00014	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NCF2—obesity	2.37e-05	0.00014	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PPARA—obesity	2.34e-05	0.000138	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—APOA5—obesity	2.33e-05	0.000137	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SDC3—obesity	2.33e-05	0.000137	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NAMPT—obesity	2.32e-05	0.000137	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—GCK—obesity	2.3e-05	0.000136	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—IAPP—obesity	2.29e-05	0.000135	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—APOC3—obesity	2.29e-05	0.000135	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—IL6—obesity	2.28e-05	0.000135	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—HK2—obesity	2.27e-05	0.000134	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—STS—obesity	2.27e-05	0.000134	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CYP26B1—obesity	2.27e-05	0.000134	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC2A4—obesity	2.27e-05	0.000134	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—AGT—obesity	2.26e-05	0.000134	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—CYCS—obesity	2.24e-05	0.000132	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—obesity	2.24e-05	0.000132	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PPARD—obesity	2.22e-05	0.000131	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—SLC22A1—obesity	2.22e-05	0.000131	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CLOCK—obesity	2.22e-05	0.000131	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—APOE—obesity	2.22e-05	0.000131	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—obesity	2.2e-05	0.00013	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—SDC1—obesity	2.2e-05	0.00013	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—CAV1—obesity	2.2e-05	0.00013	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—APOA1—obesity	2.19e-05	0.000129	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SLC27A1—obesity	2.18e-05	0.000129	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—NCOA1—obesity	2.17e-05	0.000128	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—SULT2A1—obesity	2.17e-05	0.000128	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GLP1R—obesity	2.17e-05	0.000128	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—AKR1C3—obesity	2.16e-05	0.000128	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GLUL—obesity	2.14e-05	0.000126	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—FABP4—obesity	2.14e-05	0.000126	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—DPYD—obesity	2.13e-05	0.000126	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—PLG—obesity	2.11e-05	0.000125	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—AKT1—obesity	2.11e-05	0.000124	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PRKAR2B—obesity	2.05e-05	0.000121	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—DCN—obesity	2.04e-05	0.00012	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—HSD11B1—obesity	2.03e-05	0.00012	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—UCP3—obesity	2.03e-05	0.00012	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—UCP2—obesity	2.03e-05	0.00012	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ECHS1—obesity	2.03e-05	0.00012	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—GOT2—obesity	2.01e-05	0.000119	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—obesity	2e-05	0.000118	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ADH1B—obesity	1.99e-05	0.000118	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CPT1A—obesity	1.98e-05	0.000117	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—FASN—obesity	1.97e-05	0.000116	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ACSL1—obesity	1.96e-05	0.000116	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GPAM—obesity	1.96e-05	0.000116	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PPARGC1B—obesity	1.96e-05	0.000116	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PARP1—obesity	1.96e-05	0.000116	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—GNB3—obesity	1.96e-05	0.000116	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—HMOX1—obesity	1.95e-05	0.000115	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—NAMPT—obesity	1.94e-05	0.000115	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PPARG—obesity	1.93e-05	0.000114	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GCK—obesity	1.93e-05	0.000114	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—LIPC—obesity	1.93e-05	0.000114	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—APOC3—obesity	1.92e-05	0.000113	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—GNAS—obesity	1.91e-05	0.000112	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—POMC—obesity	1.9e-05	0.000112	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—FADS1—obesity	1.9e-05	0.000112	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—HADH—obesity	1.9e-05	0.000112	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PCK1—obesity	1.9e-05	0.000112	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—obesity	1.87e-05	0.00011	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—APOB—obesity	1.87e-05	0.00011	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—obesity	1.86e-05	0.00011	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CETP—obesity	1.86e-05	0.00011	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ACP5—obesity	1.85e-05	0.000109	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NOS1—obesity	1.84e-05	0.000109	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—SDC1—obesity	1.84e-05	0.000109	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—obesity	1.83e-05	0.000108	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—TCF7L2—obesity	1.82e-05	0.000108	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—AKR1C3—obesity	1.81e-05	0.000107	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—G6PD—obesity	1.81e-05	0.000107	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—SLC2A4—obesity	1.79e-05	0.000106	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—SCARB1—obesity	1.78e-05	0.000105	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—HK1—obesity	1.78e-05	0.000105	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SREBF2—obesity	1.78e-05	0.000105	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—obesity	1.76e-05	0.000104	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—obesity	1.74e-05	0.000103	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—ALB—obesity	1.74e-05	0.000102	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—GOT1—obesity	1.74e-05	0.000102	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—SREBF1—obesity	1.73e-05	0.000102	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—LPA—obesity	1.72e-05	0.000102	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PRL—obesity	1.71e-05	0.000101	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—LPIN1—obesity	1.69e-05	9.94e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GOT2—obesity	1.68e-05	9.94e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—obesity	1.66e-05	9.8e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—APOA5—obesity	1.65e-05	9.74e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—FASN—obesity	1.65e-05	9.72e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—BCHE—obesity	1.64e-05	9.68e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—FOXO3—obesity	1.63e-05	9.6e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—obesity	1.59e-05	9.36e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CYP2E1—obesity	1.58e-05	9.34e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SLC22A1—obesity	1.58e-05	9.29e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CLOCK—obesity	1.58e-05	9.29e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—PPARA—obesity	1.57e-05	9.29e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—NQO1—obesity	1.57e-05	9.24e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SULT2A1—obesity	1.54e-05	9.06e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GLP1R—obesity	1.54e-05	9.06e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—obesity	1.53e-05	9.05e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—DPYD—obesity	1.51e-05	8.91e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—SLC2A4—obesity	1.5e-05	8.86e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GCG—obesity	1.5e-05	8.86e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CYCS—obesity	1.48e-05	8.74e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—APOA1—obesity	1.48e-05	8.72e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—APOB—obesity	1.47e-05	8.69e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GGT1—obesity	1.45e-05	8.58e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PRKAR2B—obesity	1.45e-05	8.58e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GOT1—obesity	1.45e-05	8.58e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—DCN—obesity	1.44e-05	8.52e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—NCOA1—obesity	1.43e-05	8.45e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CYP19A1—obesity	1.41e-05	8.33e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—STK11—obesity	1.41e-05	8.33e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—LPL—obesity	1.41e-05	8.3e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CPT1A—obesity	1.4e-05	8.28e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—FOXO1—obesity	1.4e-05	8.24e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—NAMPT—obesity	1.38e-05	8.12e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—LIPC—obesity	1.37e-05	8.07e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GCK—obesity	1.37e-05	8.07e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—APOC3—obesity	1.36e-05	8.02e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CETP—obesity	1.32e-05	7.79e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—COMT—obesity	1.31e-05	7.74e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SDC1—obesity	1.31e-05	7.7e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—obesity	1.3e-05	7.65e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PRKCD—obesity	1.3e-05	7.65e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GNB3—obesity	1.29e-05	7.63e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PPARGC1A—obesity	1.29e-05	7.63e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—HMOX1—obesity	1.29e-05	7.6e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—AKR1C3—obesity	1.28e-05	7.58e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—MTHFR—obesity	1.27e-05	7.47e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SCARB1—obesity	1.26e-05	7.46e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GNAS—obesity	1.26e-05	7.43e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—APOB—obesity	1.23e-05	7.28e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SREBF1—obesity	1.23e-05	7.24e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—IRS2—obesity	1.2e-05	7.11e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GOT2—obesity	1.19e-05	7.04e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—APOE—obesity	1.18e-05	6.96e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—LPL—obesity	1.18e-05	6.95e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—ALB—obesity	1.17e-05	6.91e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—FASN—obesity	1.17e-05	6.89e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CAV1—obesity	1.17e-05	6.89e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—APOA1—obesity	1.17e-05	6.88e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—BCHE—obesity	1.16e-05	6.86e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GPX1—obesity	1.15e-05	6.78e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CYP2E1—obesity	1.12e-05	6.62e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CD36—obesity	1.12e-05	6.6e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—NQO1—obesity	1.11e-05	6.55e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—BAD—obesity	1.1e-05	6.48e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GCG—obesity	1.06e-05	6.28e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SLC2A4—obesity	1.06e-05	6.28e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—MTHFR—obesity	1.06e-05	6.26e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—IRS1—obesity	1.05e-05	6.21e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CYCS—obesity	1.05e-05	6.2e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PPARA—obesity	1.04e-05	6.14e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GOT1—obesity	1.03e-05	6.08e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GGT1—obesity	1.03e-05	6.08e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—NCOA1—obesity	1.02e-05	5.99e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—AGT—obesity	1.01e-05	5.95e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—INS—obesity	1.01e-05	5.94e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—STK11—obesity	1e-05	5.9e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CYP19A1—obesity	1e-05	5.9e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—APOE—obesity	9.87e-06	5.83e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CAV1—obesity	9.78e-06	5.77e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—APOA1—obesity	9.76e-06	5.76e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—AKT2—obesity	9.73e-06	5.74e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PIK3CD—obesity	9.35e-06	5.52e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	9.35e-06	5.51e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—COMT—obesity	9.3e-06	5.49e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—SERPINE1—obesity	9.25e-06	5.46e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GNB3—obesity	9.17e-06	5.41e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PPARGC1A—obesity	9.17e-06	5.41e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—HMOX1—obesity	9.13e-06	5.39e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—TYK2—obesity	9e-06	5.31e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GNAS—obesity	8.93e-06	5.27e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—RHOA—obesity	8.92e-06	5.27e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PIK3CG—obesity	8.91e-06	5.26e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NOS3—obesity	8.83e-06	5.21e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PIK3R1—obesity	8.83e-06	5.21e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—APOB—obesity	8.74e-06	5.16e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PPARG—obesity	8.6e-06	5.07e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—POMC—obesity	8.48e-06	5e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—INS—obesity	8.43e-06	4.98e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—LPL—obesity	8.35e-06	4.93e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—MTOR—obesity	8.15e-06	4.81e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PIK3CB—obesity	8.15e-06	4.81e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GPX1—obesity	8.15e-06	4.81e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CD36—obesity	7.93e-06	4.68e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PIK3CD—obesity	7.83e-06	4.62e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ALB—obesity	7.73e-06	4.56e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—MTHFR—obesity	7.52e-06	4.44e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PIK3R1—obesity	7.4e-06	4.36e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—NOS3—obesity	7.4e-06	4.36e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PPARA—obesity	7.38e-06	4.35e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—AGT—obesity	7.14e-06	4.21e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—APOE—obesity	7e-06	4.13e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CAV1—obesity	6.93e-06	4.09e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—APOA1—obesity	6.92e-06	4.08e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PIK3CB—obesity	6.83e-06	4.03e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PIK3CG—obesity	6.32e-06	3.73e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—STAT3—obesity	6.3e-06	3.72e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PPARG—obesity	6.1e-06	3.6e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—POMC—obesity	6.01e-06	3.55e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—INS—obesity	5.98e-06	3.53e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—MYC—obesity	5.85e-06	3.45e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—TGFB1—obesity	5.84e-06	3.45e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PIK3CD—obesity	5.55e-06	3.28e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ALB—obesity	5.48e-06	3.23e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PIK3R1—obesity	5.24e-06	3.09e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—NOS3—obesity	5.24e-06	3.09e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PIK3CA—obesity	4.97e-06	2.93e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PIK3CB—obesity	4.84e-06	2.86e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PTGS2—obesity	4.8e-06	2.83e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—IL6—obesity	4.4e-06	2.6e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PIK3CA—obesity	4.16e-06	2.46e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—AKT1—obesity	4.06e-06	2.4e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—AKT1—obesity	3.4e-06	2.01e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PIK3CA—obesity	2.95e-06	1.74e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—AKT1—obesity	2.41e-06	1.42e-05	CbGpPWpGaD
